Evidence map›Paper›PMID 34442512›Full record

ArticleMicromachines2021

Toward Development of a Higher Flow Rate Hemocompatible Biomimetic Microfluidic Blood Oxygenator.

Jose Santos, Else M Vedula, Weixuan Lai, Brett C Isenberg, Diana J Lewis, Dan Lang, David Sutherland, Teryn R Roberts, George T Harea, Christian Wells and 11 more

Abstract read
In one paragraph

Article in Micromachines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. A System for the Qualitative Testing of Microfluidic Artificial Lungs Using Water.International journal of engineering and technology : IJET · 2024
    Article
  4. A Clinical-Scale Microfluidic Respiratory Assist Device with 3D Branching Vascular Networks.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  5. Review
  6. Current and Future Engineering Strategies for ECMO Therapy.Advances in experimental medicine and biology · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Jose SantosDraper, Cambridge, MA 02139, USA.
Else M VedulaDraper, Cambridge, MA 02139, USA.
Weixuan LaiDraper, Cambridge, MA 02139, USA.
Brett C IsenbergDraper, Cambridge, MA 02139, USA.ORCID 0000-0001-7208-8804
Diana J LewisDraper, Cambridge, MA 02139, USA.ORCID 0000-0002-1268-4492
Dan LangDraper, Cambridge, MA 02139, USA.
David SutherlandDraper, Cambridge, MA 02139, USA.
Teryn R RobertsAutonomous Reanimation and Evacuation (AREVA) Research Program, The Geneva Foundation, Brooks City Base, San Antonio, TX 78006, USA.
George T HareaAutonomous Reanimation and Evacuation (AREVA) Research Program, The Geneva Foundation, Brooks City Base, San Antonio, TX 78006, USA.
Christian WellsDraper, Cambridge, MA 02139, USA.
Bryan TeeceDraper, Cambridge, MA 02139, USA.
Paramesh KarandikarDraper, Cambridge, MA 02139, USA.ORCID 0000-0002-3529-2037
Joseph UrbanDraper, Cambridge, MA 02139, USA.
Thomas RisoleoDraper, Cambridge, MA 02139, USA.
Alla GimbelDraper, Cambridge, MA 02139, USA.
Derek SoltThrombodyne, Inc., Salt Lake City, UT 84103, USA.
Sahar LeazerDepartment of Medicine, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Kevin K ChungDepartment of Medicine, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.ORCID 0000-0002-2781-3787
Sivaprasad SukavaneshvarThrombodyne, Inc., Salt Lake City, UT 84103, USA.
Andriy I BatchinskyAutonomous Reanimation and Evacuation (AREVA) Research Program, The Geneva Foundation, Brooks City Base, San Antonio, TX 78006, USA.
Jeffrey T BorensteinDraper, Cambridge, MA 02139, USA.ORCID 0000-0002-4482-3274

Funding

U.S. Army Medical Research Acquisition Activity W81XWH18PRMRPTTDA
6 · The paper itself

Abstract

The recent emergence of microfluidic extracorporeal lung support technologies presents an opportunity to achieve high gas transfer efficiency and improved hemocompatibility relative to the current standard of care in extracorporeal membrane oxygenation (ECMO). However, a critical challenge in the field is the ability to scale these devices to clinically relevant blood flow rates, in part because the typically very low blood flow in a single layer of a microfluidic oxygenator device requires stacking of a logistically challenging number of layers. We have developed biomimetic microfluidic oxygenators for the past decade and report here on the development of a high-flow (30 mL/min) single-layer prototype, scalable to larger structures via stacking and assembly with blood distribution manifolds. Microfluidic oxygenators were designed with biomimetic in-layer blood distribution manifolds and arrays of parallel transfer channels, and were fabricated using high precision machined durable metal master molds and microreplication with silicone films, resulting in large area gas transfer devices. Oxygen transfer was evaluated by flowing 100% O

Indexed as

extracorporealhemocompatibilitylungmicrofluidicsoxygenator

Identifiers

PMID34442512
PMCPMC8398684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.